Moreover, analysis of CML patients showed an inverse expression of STAIP1 and STAT3 mRNA levels, ratifying that IM-resistant patients present low STATIP1/high STAT3 mRNA levels. This evidence concerns the gene STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive.